LINC02516

Across TCGA pan-cancer cohorts, LINC02516 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC02516 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02516 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02516 expression acts as an unfavorable survival marker, although some lineages such as COAD and READ show a favorable association.

COAD, READ, and UCS are the cancer types where LINC02516 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	II,III,IV	0.751	0.501	<.001	112	view →
READ	OS	Median	II,III,IV	0.761	0.291	.001	37	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
UVM	DFS	Quartile	III,IV	0.398	0.837	.017	35	view →
KIRP	OS	Quartile	II,III,IV	0.798	0.372	.012	31	view →
LGG	DFS	Median	All	0.782	0.876	<.001	31	view →
ACC	OS	Tertile	IV	0.339	0.968	.002	28	view →
KIRC	DFS	Quartile	All	0.754	0.860	.010	24	view →
BLCA	DFS	Quartile	II,III,IV	0.468	0.294	.019	21	view →
SKCM	OS	Tertile	IV	0.765	0.267	.003	18	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	18	view →
ESCA	OS	Tertile	III,IV	0.653	0.389	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC02516–COAD (OS)

Open the COAD breakdown →